Zuellig Pharma, a leading healthcare services provider in Asia, has announced that it has acquired a controlling stake in Alliance Pharma (Cambodge), a leading healthcare distributor of Cambodia.

Alliance Pharma (Cambodge) has been providing international healthcare companies with a full range of services designed to facilitate access to the Cambodian market since 2001. Over the years, Alliance Pharma (Cambodge) has developed a full-scale WHO-GSDP certified distribution infrastructure for vaccines, cold-chain products as well as pharmaceutical products, operated by approximately 400 experts in distribution and sales & marketing.

“We are excited to grow our presence in Cambodia. This acquisition will give Zuellig Pharma a market-leading position in Cambodia, strengthen our presence in Indochina and offer a great platform for accelerated growth in Cambodia and in the region for Zuellig Pharma and its clients,” said Yves Hermes, Area Director for Southeast Asia for Zuellig Pharma.

“Our vision is to further enhance access to healthcare for Cambodian people with our combined reach and capabilities in Cambodia. We will keep investing in innovative solutions for the benefit of the patients in Cambodia” added Frederik Meerhoff, Country Manager for Zuellig Pharma group of companies in Cambodia.

As one of the largest healthcare services groups in Asia, Zuellig Pharma aims to strengthen its presence across Asia to deliver on the promise of making healthcare more accessible in the region.

Through this acquisition, Zuellig Pharma will continue to provide quality service and bring innovative programmes and products to help promote health and well-being for the people of Cambodia.